TerrAscend Corp Net Income Over Time
| TSND Stock | 0.83 0.05 6.41% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out TerrAscend Corp Performance and TerrAscend Corp Correlation. TerrAscend |
Cross Equities Net Income Analysis
Compare TerrAscend Corp and related stocks such as OrganiGram Holdings, Canopy Growth Corp, and Eupraxia Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OGI | (140.2 K) | (140.2 K) | (375.2 K) | (239 K) | (1.3 M) | 846.7 K | (10.9 M) | 20.5 M | (9.5 M) | (136.2 M) | (130.7 M) | (14.3 M) | (229.5 M) | (45.4 M) | (24.8 M) | (22.3 M) | (23.4 M) |
| WEED | (26.9 K) | (21.4 K) | (64.6 K) | (932.9 K) | (8.9 M) | (3.5 M) | (16.6 M) | (54.1 M) | (670.1 M) | (1.4 B) | (1.7 B) | (310 M) | (3.3 B) | (657.3 M) | (598.1 M) | (8.9 M) | (9.4 M) |
| EPRX | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (13.2 M) | (7.2 M) | (4 M) | (23 M) | (23.3 M) | (37.4 M) | (34.9 M) | (31.4 M) | (29.9 M) |
| CPH | (9.9 M) | (2.3 M) | 2.6 M | 23.4 M | (4.8 M) | 1.8 M | (39.1 M) | 4.4 M | 543 K | 3.2 M | 4.5 M | 7.8 M | 26.6 M | 20.4 M | 11.5 M | 13.3 M | 13.9 M |
| XLY | (15.6 K) | 84.3 K | 105.2 K | 62.3 K | 37.3 K | 32.5 K | (229.6 K) | (18.2 M) | (67 M) | (108.6 M) | (87.4 M) | (45.9 M) | (130.3 M) | (44.5 M) | (16.3 M) | (14.7 M) | (15.4 M) |
| FRX | (1.6 M) | 4.7 M | (5.2 M) | 1.8 M | (2.2 M) | (659 K) | (2.8 M) | (7 M) | (9.9 M) | (12.5 M) | (18.1 M) | (17.5 M) | (23.9 M) | (16 M) | (436 K) | (392.4 K) | (412 K) |
| DR | (10.9 M) | (15.4 M) | 32.8 M | 11 M | 23.3 M | 47.1 M | 9.8 M | 20.6 M | 20.9 M | 9.8 M | 8.8 M | 15.5 M | (4.4 M) | 18.5 M | 73.5 M | 84.5 M | 88.7 M |
| ACB | 1.3 K | (315.8 K) | (393.5 K) | (399.7 K) | (9.5 M) | (5.7 M) | (13 M) | 71.9 M | (293.5 M) | (3.3 B) | (693.6 M) | (1.7 B) | (265.3 M) | (69.3 M) | 1.6 M | 1.4 M | 1.5 M |
| HLS | 6.9 M | 12 M | 16.9 M | 9.7 M | 12.7 M | (1.7 M) | (874.9 K) | (6.1 M) | (24.8 M) | (19.6 M) | (15.3 M) | (13.1 M) | (23.6 M) | (27.5 M) | (19.7 M) | (17.7 M) | (16.8 M) |
TerrAscend Corp and related stocks such as OrganiGram Holdings, Canopy Growth Corp, and Eupraxia Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in TerrAscend Corp financial statement analysis. It represents the amount of money remaining after all of TerrAscend Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| TerrAscend Corp | TSND |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 357 South Gulph |
| Exchange | Toronto Exchange |
null 0.83
Other Information on Investing in TerrAscend Stock
TerrAscend Corp financial ratios help investors to determine whether TerrAscend Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TerrAscend with respect to the benefits of owning TerrAscend Corp security.